Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
Home » Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)

GH AMEA on Social Media Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
GH AMEA

Calling All Pharmaceutical Industry Professionals and Medical Oncologists! Join us on 11 Dec at 1pm (GMT+9hrs) for a Webinar Discussion on “Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers”. This webinar will feature a leading medical oncologist from Japan, Dr. Yoshiaki Nakamura MD, PhD. We look forward to your participation. Contact us at press@guardantamea.com to register before 10 December.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Open chat
Message us
Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar) - Guardant Health AMEA

Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
Home » Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)

GH AMEA on Social Media Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers (Webinar)
GH AMEA

Calling All Pharmaceutical Industry Professionals and Medical Oncologists! Join us on 11 Dec at 1pm (GMT+9hrs) for a Webinar Discussion on “Liquid versus Tissue Biopsy for Clinical Trial Enrollment in Gastrointestinal Cancers”. This webinar will feature a leading medical oncologist from Japan, Dr. Yoshiaki Nakamura MD, PhD. We look forward to your participation. Contact us at press@guardantamea.com to register before 10 December.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Open chat
Message us